Yoshitake Sato
About
In The Last Decade
Yoshitake Sato
67 papers receiving 554 citations
Peers
Comparison fields: 5 of 81
- Epidemiology 362
- Microbiology 243
- Pharmacology 101
- Molecular Medicine 74
- Molecular Biology 67
Countries citing papers authored by Yoshitake Sato
This map shows the geographic impact of Yoshitake Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitake Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitake Sato more than expected).
Fields of papers citing papers by Yoshitake Sato
This network shows the impact of papers produced by Yoshitake Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitake Sato. The network helps show where Yoshitake Sato may publish in the future.
Co-authorship network of co-authors of Yoshitake Sato
This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitake Sato. A scholar is included among the top collaborators of Yoshitake Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitake Sato. Yoshitake Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | Clinical Efficacy of Tebipenem Pivoxil Treatment in Children with Pneumonia Classified According to Guideline-based Severity | 1 |
| 3 | 16 | |
| 4 | 8 | |
| 5 | 11 | |
| 6 | 22 | |
| 7 | 96 | |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 6 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | A mouse model of Escherichia coli .O157: H7 infection for evaluation of antibacterial drugs - In vivo release of verotoxins and toxic effect on mice | 3 |
| 14 | [Pharmacokinetic and clinical studies on flomoxef in neonates and premature infants]. | 2 |
| 15 | [Pharmacokinetic and bacteriological studies on sulbactam/ampicillin in the field of pediatrics]. | 2 |
| 16 | 1 | |
| 17 | [Fundamental and clinical studies of ceftizoxime suppositories in the pediatric field]. | 1 |
| 18 | 2 | |
| 19 | 1 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.